The Jackson Laboratory (JAX) is partnering with Wuhan Frasergen Bioinformatics to create a biomedical research center in Wuhan, China. The facility will support the transfer of basic research to clinical care to provide personalized medicine solutions for cancer and hereditary diseases. JAX's immunocompromised mice will be used as hosts for tumors donated by Chinese patients to enable the development of pharmaceutical therapies.
Tufts University received permission from the Boston Public Health Commission in June of 2014 to begin operating the Arnold 8 Biosafety Laboratory. Supporting tuberculosis research, the BSL-3 facility is located in the Tufts School of Medicine’s Biomedical Research and Public Health Building. Development of the 1,700-sf lab began in spring of 2012 with construction commencing in February of 2013. The project architect was Shawmut Design & Construction.
The University of Tampere began construction in June of 2014 on a $64 million medical teaching and research building in Finland. The 273,400-sf project is being built by NCC Construction and will provide instructional space, teaching and research labs, and administrative offices. Completion is expected in May of 2016.
HemoShear occupied its new headquarters and research facility in Charlottesville in May of 2014. The renovated building provides 16,000 sf of lab and office space with 12,000 sf to accommodate future growth. The facility will accommodate streamlined R&D operations with advanced instrumentation to support HemoShear's translational human tissue platforms and predictive bioanalytics for pharmaceutical discovery.
The University of Arizona is planning to build the $136 million Biosciences Partnership Building in Phoenix. Supporting collaborative research, the 10-story, 245,000-sf facility will be located adjacent to the university’s new cancer center currently under construction on the Phoenix Biomedical Campus. Construction will begin by year-end 2014 with completion expected in early 2017.
The Karolinska Institute is planning the second phase of construction at the Medical Research Laboratory in Solna, Sweden. Project developer Akademiska Hus AB has awarded Skanska a $61 million contract to construct a nine-story, 183,000-sf interdisciplinary research building. The first phase of construction at the Biomedicum campus is a $190 million, 678,000-sf facility, which is also being built by Skanska with completion slated for 2018.
Cubresa introduced a compact, affordable SPECT scanner for preclinical research in early 2014. The scanner attaches to existing small animal CT systems, transforming them into multi-modality molecular imaging systems for disease study, translational research, and drug discovery applications. The product features a slim bore which positions the imaging detectors close to the animal subject, optimizing spatial resolution. Advanced detector technology improves sensitivity to balance radiation dose with accelerated study throughput.
Rochester Institute of Technology broke ground on the Clinical Health Sciences Center in April of 2014 in Henrietta, N.Y. Accommodating programs for the College of Health Sciences and Technology, the 45,000-sf facility will include dedicated space for the new Wegmans School of Health and Nutrition as well as housing a primary care clinic operated by Rochester General Health System. Constructed as an addition to the existing Louise M.
Grifols’ North Fractionation Facility in Clayton, N.C., has been named the International Society for Pharmaceutical Engineering (ISPE) 2014 Facility of the Year for Project Execution. Fluor provided integrated engineering, procurement, construction management, and front-end qualification for this 150,000-sf blood plasma fractionation facility, which was built using modular construction techniques to meet an aggressive construction schedule, incorporate new centrifuge technology, and expand existing plant utilities.
The National Institutes of Health dedicated the John Edward Porter Neuroscience Research Center in late March of 2014 in Bethesda, Md. Comprised of two buildings connected by a glass atrium, the collaborative 500,000-sf facility provides open laboratories, offices, and an advanced MRI suite for researchers from 10 NIH neuroscience institutes and centers. Construction on the first building began in 2001 and was completed in 2004.
The University of North Carolina at Chapel Hill dedicated the $245 million Marsico Hall in March of 2014. The nine-story, 340,000-sf biomedical imaging facility will support basic and translational research in oncology, nanomedicine, microbiology, immunology, and pharmaceutical engineering. Marisco Hall houses a hybrid MRI/PET whole body scanner, a 7 Tesla MRI whole body scanner, and a cyclotron.
The University of California, San Diego dedicated the $113 million Health Sciences Biomedical Research Facility in March of 2014 in La Jolla, Calif. Designed by ZGF Architects, the 196,000-sf building provides wet bench laboratories, open lab space, lab support, offices, conference rooms, and an interaction atrium. A basement level accommodates core labs and mechanical systems.
Hamad Medical Corporation opened the Interim Translational Research Institute (iTRI) in March of 2014 in Doha, Qatar. Located in Hamad Bin Khalifa Medical City, the facility will support advanced biomedical research in genomics, cancer, cardiovascular diseases, diabetes, respiratory medicine, and neurosciences. The iTRI includes wet laboratories, a clinical studies unit, a conference center, and core labs for sample analysis and other services.
The Public Health Agency of Canada opened the 60,000-sf JC Wilt Infectious Diseases Centre in February of 2014 in Winnipeg. Designed by Smith Carter, the facility provides advanced laboratories for infectious diseases research, diagnostic testing, and early stage vaccine development. Housing up to 200 employees, the Centre includes a training area for biocontainment laboratory operations. The facility will also support research on HIV/AIDS and antimicrobial resistant organisms.
The 183,500-sf Jackson Laboratory (JAX) for Genomic Medicine aims to advance genomic research not only by way of its location—on the campus of a university health center near major research institutions, hospitals, and urban research corridors—but also by utilizing an interior design that comingles the computational and wet lab aspects of research and encourages collaboration. The ultimate goal is to enable quicker development of disease-fighting therapies targeted at individual patients.
